溃疡性结肠炎研究进展:中药通过肠道菌群与信号通路的作用
本文综述了溃疡性结肠炎(UC)的研究现状,重点讨论中药(活性成分、提取物及复方)通过调控TLR4、STAT3、PI3K/Akt、NF-κB和Keap1/Nrf2等信号通路及肠道菌群,抑制肠道炎症细胞浸润、减轻氧化反应、修复肠屏障的机制,为中药治疗UC及预防炎症相关结直肠癌提供参考。
要点
- 中药可通过多信号通路与肠道菌群协同作用治疗UC。
- 中药在UC治疗中显示良好疗效、高治愈率及较少不良反应。
- 中药有望作为UC的补充替代疗法并降低癌变倾向。
核心结论
- 中药通过联合调控信号通路与肠道菌群,可抑制肠道炎症细胞浸润、减轻氧化反应并修复肠屏障。
- 中药在UC治疗中疗效好、治愈率高、不良反应少,并可改善患者生存质量、降低癌变倾向。
研究设计与样本
- 本文为综述,评估和讨论了UC、信号通路及肠道菌群的最新研究。
- 文章总结了多种中药(活性成分或提取物)及复方通过信号通路和肠道菌群的作用机制。
主要发现
- 中药可抑制TLR4、STAT3、PI3K/Akt、NF-κB和Keap1/Nrf2等多个信号通路。
- 中药通过信号通路与肠道菌群的联合调控,可单独或协同抑制肠道炎症细胞浸润、减轻肠道氧化反应并修复肠道屏障。
临床怎么用
- 中药可作为UC的补充替代疗法,通过多靶点调控信号通路和肠道菌群发挥治疗作用。
- 中药治疗有助于改善UC患者生存质量并降低癌变倾向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ulcerative colitis (UC), one among other refractory diseases worldwide, has shown an increasing trend of progression to colorectal cancer in recent years. In the treatment of UC, traditional Chinese medicine has demonstrated good efficacy, with a high cure rate, fewer adverse effects, great improvement in the quality of patient survival, and reduction in the tendency of cancerous transformation. It shows promise as a complementary and alternative therapy. This review aims to evaluate and discuss the current research on UC, signaling pathways, and gut microbiota. We also summarized the mechanisms of action of various Chinese medicines (active ingredients or extracts) and herbal formulas, through signaling pathways and gut microbiota, with the expectation that they can provide references and evidence for treating UC and preventing inflammation-associated colorectal cancer by traditional Chinese medicine. We illustrate that multiple signaling pathways, such as TLR4, STAT3, PI3K/Akt, NF-[Formula: see text]B, and Keap1/Nrf2, can be inhibited by Chinese herbal treatments through the combined regulation of signaling pathways and gut microbiota, which can act individually or synergistically to inhibit intestinal inflammatory cell infiltration, attenuate gut oxidative responses, and repair the intestinal barrier.
引用
- Zhang Y, Zhu M, Dai Y, et al. Research Progress in Ulcerative Colitis: The Role of Traditional Chinese Medicine on Gut Microbiota and Signaling Pathways. Am J Chin Med. 2024. PMID: 39756829. doi:10.1142/S0192415X24500885
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。